FDA Approves First Drug for WHIM Syndrome

(MedPage Today) -- The FDA approved mavorixafor (Xolremdi) capsules as the first therapy specifically for WHIM syndrome, a rare primary immunodeficiency and chronic neutropenic disorder, X4 Pharmaceuticals announced on Monday. Caused by CXC chemokine...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news